Загрузка...
Tau Imaging in Alzheimer’s Disease Diagnosis and Clinical Trials
In vivo imaging of the tau protein has the potential to aid in quantitative diagnosis of Alzheimer’s disease, corroborate or dispute the amyloid hypothesis, and demonstrate biomarker engagement in clinical drug trials. A host of tau positron emission tomography agents have been designed, validated,...
Сохранить в:
| Опубликовано в: : | Neurotherapeutics |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer US
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5233632/ https://ncbi.nlm.nih.gov/pubmed/27873182 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13311-016-0490-y |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|